Tenth Annual "Buying Time" Dinner

With Special Guests:

Craig Melvin

NEWS ANCHOR, “TODAY”, CO-HOST OF 3rd HOUR, TODAY AND ANCHOR ON MSNBC LIVE

Craig Melvin is an award-winning news anchor on NBC News’ “TODAY,” a co-host of 3rd Hour TODAY, an anchor on MSNBC Live, and a host of syndicated “Dateline NBC” broadcasts. His breaking news coverage and reporting appears across all NBC News and MSNBC platforms.

Melvin has covered a wide-range of news events, including several Republican and Democratic National Conventions and three Presidential Inaugurations. His coverage of politics has included notable interviews with former President Bill Clinton, Former Vice President Joe Biden, Ambassador Nikki Haley, and Secretaries of State John Kerry, Mike Pompeo and Condoleezza Rice. He has also covered tragic mass shootings across the country for the network, including Dallas and Orlando in 2016; Charleston, South Carolina in 2015; the Navy Yard in Washington, D.C. in 2013; and Sandy Hook in 2012. Melvin reported extensively on police involved shootings and subsequent protests nationwide.

In addition, he has also covered two Olympic Games and six Super Bowls. Prior to joining NBC News and MSNBC in July 2011, Melvin was a weekend anchor for WRC, NBC’s owned-and-operated station in Washington, DC. Before that, Melvin earned acclaim as an evening news anchor at WIS in Columbia, South Carolina, which is also his hometown.

Melvin is a graduate of Wofford College in Spartanburg, South Carolina where he serves on the board of trustees. He is an active member in several charities, including the Colorectal Cancer Alliance.

Melvin lives in Connecticut with his wife, awarding winning sportscaster Lindsay Czarniak, who is a Fox Sports reporter and the host of the podcast “The Artist and The Athlete.” They have a son and daughter.

Melvin is on Twitter at @craigmelvin.

••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••

Dr Scott Kopetz,

Professor, Deputy Chair

Department of Gastrointestinal Medical Oncology

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Dr. Scott Kopetz received his medical degree from Johns Hopkins School of Medicine after an undergraduate degree in Electrical and Biomedical Engineering at Vanderbilt University. He obtained his residency training in Internal Medicine at Duke University Medical Center, followed by a medical oncology fellowship at M. D. Anderson Cancer Center. He subsequently completed a Ph.D. at M.D. Anderson in Cancer Biology.

Dr. Kopetz is currently Deputy Chair of the Department of Gastrointestinal Medical Oncology and Program Leader of the GI Program of the Cancer Center Support Grant at UTMDACC. Dr. Kopetz is well versed in multidisciplinary care of and translational research for GI cancer patients. His laboratory is funded by multiple NIH-funded grants. He serves as chair of the Colon Cancer Task Force, and is Vice-Chair for Colon Cancer in the NSABP/RTG/GOG (NRG) Cooperative Group. Dr. Kopetz is a leader of the GI Cancer Center Support Grant at MD Anderson and the Colorectal Cancer Moonshot, a multi- disciplinary effort to improve the survival of this disease beyond incremental advances. He has authored over 300 peer-reviewed articles in respected scientific journals such as New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Lancet, Nature Reviews Cancer, Cancer Research, Lancet Oncology, Clinical Cancer Research, and JAMA. He is a senior editor for Clinical Cancer Research. Dr. Kopetz has developed a translational and clinical trial program in BRAF-mutated colorectal cancer, which has resulted in addition of combination therapy with a BRAF inhibitor to the current treatment guidelines. He also co-lead the clinical trial resulting in the FDA-approval of nivolumab and ipilimumab for mismatch repair deficient tumors. He also is an innovator in the development and implementation of circulating tumor DNA into clinical management, including interrogation of mechanisms of resistance, evaluation of minimal residual disease, and integration into clinical trial designs. Further research efforts include the development of the Consensus Molecular Subtypes, an RNA- based methodology for CRC classification that is now being widely integrated in retrospective and clinical trial efforts.

Thursday, November 18, 2021

Winged Foot Golf Club

6:00 pm Cocktails | 7:30 pm Dinner

Live Auction - Bring your “A” game!

Tickets

Checks only to The Danny Butler Memorial Fund (the "Fund").
6 Martin Butler Court, Rye, NY 10580

All donations are fully tax deductible to the extent permitted by law.
The non-tax deductible portion of each ticket is $250.
No tickets at the door.

Accommodations

Block of rooms are reserved at Westchester Country Club
through Mike Iuliano 914.967.600